Navigation Links
Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Date:7/24/2008

2 testing. Product candidates in Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with Endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza, is available online at http://www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development, therapeutic potential and safety of AZ-004, the development of the Company's product candidates, projected clinical trial enrollment and data reporting timelines, and safety of the Company's products and technologies. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission, including the risks under the headings: "Failure or delay in commencing or completing clinical trials for our product candidates could harm our business" and "If our product candidates do not meet safety and efficacy endpoints in clinical trials, they will not receive regulatory approval, and we will be unable to market them." Forward-looking statements contained in this announcement are made as of this date,
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
2. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
3. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
4. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
5. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
6. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
7. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
8. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
9. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
10. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
11. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... and MUNICH , May 22, 2013 /PRNewswire/ ... marketer of transcatheter aortic valve implantation (TAVI) systems for the ... results of the J enaValve Eval U ation of ... Pa T ients with S E vere Ao R tic ... . JUPITER is a post-market registry to evaluate five-year long ...
(Date:5/22/2013)... May 22, 2013  The Lupus Research Institute (LRI) ... advancing new treatments for lupus nephritis, a serious kidney ... patients. The conference launched a new international alliance of ... Trials Network (LNTN). More than 50 of ... came together to focus on two critical questions: 1) ...
(Date:5/22/2013)... -- The new 13-valent pneumococcal conjugate vaccine (PCV13) appears ... prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), ... Vaccine. The U.S. Food and Drug Administration ... series of trials. These trials found that PCV13, which ... the previously used PCV7, did not increase the risk ...
Breaking Medicine Technology:First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4
(Date:5/22/2013)... May 22, 2013 Jury deliberations are now ... involving a da Vinci lawsuit, Bernstein Liebhard LLP ... of a man who allegedly died of da Vinci surgery ... million in damages from Intuitive Surgical, Inc. Among other ... program for the da Vinci Surgical System in its efforts ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The Muscular ... against muscular dystrophy at the annual Charlotte Muscle Team ... to help Charlotte-area families living with muscle disease. ... year's event to support MDA families,” said MDA Divisional ... who were partnered with a "Buddy" to make their ...
(Date:5/22/2013)... Zensah® Compression Apparel released a statement regarding ... "Breast pain while running affects one-third of women ... According to the article, a British study surveyed over ... from breast pain while running but do not wear ... , Zensah emphasizes the importance for women to wear ...
(Date:5/22/2013)... there is a gender gap when it comes to ... that does not appear to exist in children in ... levels of self-regulation than boys. Self-regulation is defined as ... directions, and persist on a task. It has been ... studies by Oregon State University researchers. , In ...
(Date:5/22/2013)... People in the United States have been taking ... In much of the world, water shortages are normal and ... She warns against taking water for granted and provides ways ... easily in the United States. , Sharon Kleyne is host ... heard live or by podcast on World Talk Radio, Voice ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Charlotte Muscle Team Event Raises $300,000 in the Fight Against Muscle Disease 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2
... flight surgeons supporting Wyle and its NASA Bioastronautics Contract have ... NASA announced last week that Dr. Kjell Lindgren and Dr. ... Texas Medical Branch (UTMB) in the Department of Preventive ... from a pool of 3,565 applicants. UTMB is one of ...
... N.J., July 1 Zufall Health Center, a federally ... launched the nation,s first eco-friendly mobile medical unit. , ... needed, affordable health care to low-income, mostly uninsured residents ... officials commemorated the launch at a ribbon cutting ceremony ...
... a higher risk of hospitalization or death due to cirrhosis ... with a lower risk. These findings are in the July ... Wiley & Sons on behalf of the American Association for ... available online at Wiley Interscience ( www.interscience.wiley.com ). ...
... mother of an autistic child joined Consumer Watchdog and ... California Department of Managed Health Care ("DMHC"), the Schwarzenegger ... insurers. The suit alleges that the DMHC has wrongfully ... treatments, resulting in the denial of critically needed, medically ...
... , TeamHealth Demonstrates Ongoing Commitment to Patient Care through ... July 1 TeamHealth announced today that it has ... safety. On July 1, its patient safety organization -- ... by the Agency for Healthcare Research and Quality (AHRQ), ...
... , To Expand Access to Its Research, HealthTech Joins With Public ... CalRHIO Board of Directors has appointed Molly Joel Coye, MD, MPH, ... California statewide information exchange founded in 2005. Dr. Coye was ... of the Board of Directors since 2007. , , "Molly ...
Cached Medicine News:Health News:Two Flight Surgeons Supporting Wyle's Bioastronautics Contract Selected for New Astronaut Class 2Health News:Two Flight Surgeons Supporting Wyle's Bioastronautics Contract Selected for New Astronaut Class 3Health News:Nation's First Eco-Friendly Mobile Health Van Launched by New Jersey Non-Profit Health Center 2Health News:Nation's First Eco-Friendly Mobile Health Van Launched by New Jersey Non-Profit Health Center 3Health News:Study examines dietary influences of liver disease 2Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 2Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 3Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 4Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 5Health News:TeamHealth Recognized by National Quality Agency 2Health News:TeamHealth Recognized by National Quality Agency 3Health News:Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO 2Health News:Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO 3
... is the first compact, broad menu clinical ... in any treatment setting. Care givers can ... with less than one minute of hands-on ... in quality to larger, expensive laboratory analyzers ...
... lens, doctors have to make a trade off ... Now, with the Digital Wide Field lens ... both in one lens. This lens provides ... non-contact lens paired with the higher magnification required ...
RCB™ Rotator Cuff Buttress is a completely resorbable plate that will alleviate suture migration in open or mini-Open rotator cuff repairs....
... USS Sports Medicine™ POLYSORB™ Soft Tissue Anchor 3 ... attach soft tissue to bone using sutures. The ... hole in the bone, and is used to ... of a resorbable copolymer, derived from glycolide and ...
Medicine Products: